This company listing is no longer active
AKU Stock Overview
Akumin Inc. provides outpatient diagnostic imaging services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Akumin Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.53 |
| 52 Week High | US$1.90 |
| 52 Week Low | US$0.16 |
| Beta | 0.15 |
| 1 Month Change | 17.78% |
| 3 Month Change | 23.26% |
| 1 Year Change | -60.74% |
| 3 Year Change | -86.85% |
| 5 Year Change | -89.89% |
| Change since IPO | -89.18% |
Recent News & Updates
Recent updates
Is Akumin (TSE:AKU) Using Too Much Debt?
Apr 06
Akumin (TSE:AKU) Has A Somewhat Strained Balance Sheet
Jan 06Akumin Inc.'s (TSE:AKU) Intrinsic Value Is Potentially 83% Above Its Share Price
Oct 05Is Akumin (TSE:AKU) Using Too Much Debt?
Sep 02Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky
May 08A Look At The Fair Value Of Akumin Inc. (TSE:AKU)
Feb 05Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky
May 14Will The ROCE Trend At Akumin (TSE:AKU) Continue?
Mar 02Is Akumin (TSE:AKU) Using Too Much Debt?
Feb 04
Could The Akumin Inc. (TSE:AKU) Ownership Structure Tell Us Something Useful?
Jan 13Have Insiders Been Selling Akumin Inc. (TSE:AKU) Shares This Year?
Dec 23Will Akumin's (TSE:AKU) Growth In ROCE Persist?
Dec 02Should You Be Concerned About Akumin Inc.'s (TSE:AKU) ROE?
Jul 28Would Shareholders Who Purchased Akumin's(TSE:AKU) Stock Year Be Happy With The Share price Today?
Jul 10Does Akumin's (TSE:AKU) Statutory Profit Adequately Reflect Its Underlying Profit?
Jun 22Shareholder Returns
| AKU | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 17.8% | 1.9% | 2.3% |
| 1Y | -60.7% | 34.7% | 12.1% |
Return vs Industry: AKU underperformed the Canadian Healthcare industry which returned -2.9% over the past year.
Return vs Market: AKU underperformed the Canadian Market which returned -0.2% over the past year.
Price Volatility
| AKU volatility | |
|---|---|
| AKU Average Weekly Movement | 31.3% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 9.7% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 4.1% |
Stable Share Price: AKU's share price has been volatile over the past 3 months.
Volatility Over Time: AKU's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Riadh Zine Zine-El-Abidine | www.akumin.com |
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations.
Akumin Inc. Fundamentals Summary
| AKU fundamental statistics | |
|---|---|
| Market cap | CA$45.40m |
| Earnings (TTM) | -CA$344.24m |
| Revenue (TTM) | CA$992.76m |
0.0x
P/S Ratio-0.1x
P/E RatioIs AKU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKU income statement (TTM) | |
|---|---|
| Revenue | US$737.69m |
| Cost of Revenue | US$569.72m |
| Gross Profit | US$167.97m |
| Other Expenses | US$423.77m |
| Earnings | -US$255.79m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.81 |
| Gross Margin | 22.77% |
| Net Profit Margin | -34.68% |
| Debt/Equity Ratio | -1,459.1% |
How did AKU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/04 03:40 |
| End of Day Share Price | 2024/02/02 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Akumin Inc. is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tania Armstrong-Whitworth | Canaccord Genuity |
| Noel Atkinson | Clarus Securities Inc. |
| Kyle McPhee | Cormark Securities Inc. |